EUVIMEDEUVIMED entdecken
Crossref

Ligand‐Controlled Chemoselective and Enantioselective Cyclization of Enynes With Aroyl Chlorides

Zhen-Yu Wang, Ling-Xia Zhang, Yuqing Jiang, Yun-Qian Zhang, Tian-Qi Gao, Genping Huang iD, Hui Xu, Hui-Xiong Dai iD

Angewandte Chemie International Edition · 01.07.2026 · 65 (27)

DOI: 10.1002/anie.2250866 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Angewandte Chemie International Edition, online erschienen am 14.05.2026. Verfasst von Zhen-Yu Wang und 7 weiteren Autor:innen. Beteiligte Einrichtung: Shanghai Frontiers Science Center for Drug Target Identification and Delivery, National Key Laboratory of Innovative Immunotherapy, and Shanghai Key …. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 81 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Science and Technology Commission of Shanghai Municipality, Program of Shanghai Academic Research Leader.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Herein, we report a palladium‐catalyzed, ligand‐controlled approach for the switchable construction of cyclopropane‐fused heterocycles and seven‐membered N‐heterocyclic compounds via the chemoselective cyclization of enynes with aroyl chlorides. Furthermore, enantioselective synthesis of cyclopropane‐fused heterocycles was achieved using a chiral ligand. To highlight the synthetic utility, late‐stage modifications of acid chlorides derived from natural products and pharmaceuticals were demonstrated. DFT calculations reveal that the ligands play an important role in the chemoselective cyclization process by favoring either β‐H or β‐C elimination of the alkyl‐Pd(II) intermediate.

Schlagwörter

Stichwörter der Autor:innen

aroyl chloridescyclizationdecarbonylationenantioselectivityquaternary stereocenters

Autor:innen und Institutionen

  • Shanghai Frontiers Science Center for Drug Target Identification and Delivery, National Key Laboratory of Innovative Immunotherapy, and Shanghai Key Laboratory for Molecular Engineering of Chiral Drugs, School of Pharma…
  • State Key Laboratory of Organometallic Chemistry, Shanghai Institute of Organic Chemistry, Chinese Academy of Sciences, Shanghai, China.
  • Medicinal Basic Research Innovation Center of Chronic Kidney Disease of Ministry of Education, School of Pharmacy, Shanxi Medical University, Taiyuan, China.
  • School of Chinese Materia Medica, Nanjing University of Chinese Medicine, Nanjing, Jiangsu, China.
  • Department of Chemistry, School of Science, Tianjin University, Tianjin, P. R. China.
  • CAS Key Laboratory of Receptor Research, State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai, China.

ORCID-Profile: Genping Huang, Hui-Xiong Dai

Förderung

  • National Natural Science Foundation of China
  • Science and Technology Commission of Shanghai Municipality
  • Program of Shanghai Academic Research Leader
  • Shanghai Postdoctoral Excellence Program
  • China Postdoctoral Science Foundation

Zitieren

APA

Wang, Z. Y., Zhang, L. X., Jiang, Y., Zhang, Y. Q., Gao, T. Q., Huang, G., Xu, H., & Dai, H. X. (2026). Ligand‐Controlled Chemoselective and Enantioselective Cyclization of Enynes With Aroyl Chlorides. Angewandte Chemie International Edition, 65(27). https://doi.org/10.1002/anie.2250866

Vancouver

Wang ZY, Zhang LX, Jiang Y, Zhang YQ, Gao TQ, Huang G, et al. Ligand‐Controlled Chemoselective and Enantioselective Cyclization of Enynes With Aroyl Chlorides. Angewandte Chemie International Edition. 2026;65(27). doi:10.1002/anie.2250866

BibTeX
@article{Wang2026,
  author = {Wang, Zhen-Yu and Zhang, Ling-Xia and Jiang, Yuqing and Zhang, Yun-Qian and Gao, Tian-Qi and Huang, Genping and Xu, Hui and Dai, Hui-Xiong},
  title = {Ligand‐Controlled Chemoselective and Enantioselective Cyclization of Enynes With Aroyl Chlorides},
  journal = {Angewandte Chemie International Edition},
  year = {2026},
  volume = {65},
  number = {27},
  doi = {10.1002/anie.2250866}
}
Kostenlos starten →